Featured Articles

  1. Meeting The Rising Challenge Of Software Training For Clinical Trial Sites 10/12/2021

    The need for technology has been trending upwards for years, even before being vastly accelerated by COVID-19. As the progression of the digital age continues, technology and software have become not only the norm in our everyday lives but also the foundation upon which entire businesses and industries are built.

  2. The Financial Barriers To Decentralized Clinical Trials 9/13/2021

    While technology has certainly had a positive impact on clinical research, especially over the past year and a half, sites have felt the burden of an accelerated and decentralized trial landscape. While this burden was felt administratively, it was also felt financially, leading sites that may have already been in a financially precarious position to face additional expenses.

  3. 2021 Sponsor/CRO Survey Results 9/13/2021

    In this paper, the voices of sponsors and CROs as they address their needs at this complex juncture are highlighted.

  4. Simplifying The Clinical Trial Participant Journey — Driving Enrollment And Retention Through Technology 9/8/2021

    Access action steps your organization can take to create change across your clinical studies.

  5. Day One, Patient One: How Sponsors Can Overcome The Growing Challenges In Clinical Trial Budgeting And Negotiation 9/8/2021

    In this white paper, explore the challenges experienced by sponsors and CROs, and discover how new technology and up-to-date data is helping to generate more accurate budgets and accelerate time to FPI.

  6. Five Clinical Trial Diversity Action Steps You Can Take Today 5/24/2021

    Diversity has taken center stage in the clinical trial industry and many organizations are looking to make a difference in this arena. In this article Greenphire shares some of the key learnings from a recent DIA event that addressed diversity, equity and inclusion in the drug development lifecycle.

  7. 2021 Predictions Getting Down To Business In Clinical Trials 2/23/2021

    The COVID-19 pandemic added new obstacles and complexity on top of the already difficult environment, creating enormous adaptive pressure on the entire clinical trial ecosystem, hastening adoption of new clinical research paradigms, and accelerating emerging trends. But will they sustain? In this paper, we will delve into hot topics impacting research today.

  8. Increasing Site & Patient Convenience For Oncology Clinical Trials 2/10/2021

    According to an ACSCAN report, out of all potential qualifying patients for a trial, only 44% of them have access to an available trial, only 27% are eligible for the trial, and only 8% are able to successfully enroll. Explore some of the obstacles facing oncology research as well as innovation opportunities that transform the way sites, sponsors, and CROs interact.

  9. Decentralized Clinical Trials: Are They Here to Stay? 1/6/2021

    In 2020 the clinical trial industry adapted and responded in rapid fashion. Measures were taken to allow for continuity of studies, all while shortening timelines and ensuring safety and flexibility of care. This flexibility can be seen through trial decentralization – enabling care to be continued through varying methods, whether bringing care to the patient’s home, allowing patients to benefit from local labs or utilizing technology to complete trial requirements. This response by the industry was impressive and perhaps provides a glimpse into the future of clinical research. But what does the future look like?

  10. Advancing Diversity In Clinical Trials: Building Awareness And Implementing Solutions To Enable Broad Participation In Research 12/14/2020

    The underrepresentation of certain populations in clinical research is a serious problem. However, sponsors and CROs are renewing their focus on diversity, and are looking for new ways to create awareness and remove obstacles through patient-centered solutions.